Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment
Clinical trial NCT02789137 · COMPLETED
Trial details
- NCT number
- NCT02789137
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-12-22
- Primary completion
- 2020-10-20
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.